Investcorp buys pharma, biotech clinical trials specialist Sanos Group
Global alternative investment house Investcorp has bought pharma and biotech clinical trials specialist Sanos Group.
Global alternative investment house Investcorp has bought pharma and biotech clinical trials specialist Sanos Group.
Global private equity major KKR has agreed to acquire animal health-focused pharmaceutical business Argenta from the Tomlinson Group.
Private investment giant Ardian has bought a minority stake in H2 Pharma, a French specialist in the development and production of generic drugs.
Life sciences investor Catalio Capital Management has hit the $100m hard cap for its second venture capital fundraise.
Apax Partners is set for a 3.5x return selling its stake in European pharma company Neuraxpharm to fellow private equity major Permira, AltAssets has learned.
Global private equity giant Blackstone has brought in former Pfizer CEO and chairman Jeffrey Kindler as its latest senior advisor.
SV Health Investors has hit a $265m final close for its first dedicated biotech fundraise.
Newly-launched private equity house bd-capital has sealed its first investment by backing Symprove, a startup attempting to disrupt the £35bn probiotics market.
Global private equity giant KKR has agreed to buy a 54% stake in Indian pharmaceutical business JB Chemicals, in a deal which could ultimately see it commit $500m to the company.
UK private equity house Inflexion has agreed to carve-out liquid pharma business Rosemont Pharmaceuticals from US-listed Perrigo.
Advanced therapies-focused venture capital firm 4BIO Capital has picked up a strategic investment in its newest fund from specialist pharma and biotech business Kyowa Kirin.
